We estimate that the CEO of Aclaris Therapeutics, Inc. ($ACRS), Neal Walker, received a compensation of $3,375,591 in 2025. This is an increase of 57.19% from an estimated $1,445,135 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on April 23, 2026. Note that parsing errors may occur.
You can track $ACRS on Quiver Quantitative's $ACRS stock dashboard.
$ACRS Stock Hedge Fund Activity
We have seen 58 institutional investors add shares of $ACRS Stock stock to their portfolio, and 45 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO added 1,898,561 shares (+379712.2%) to their portfolio in Q4 2025, for an estimated $5,714,668
- MARSHALL WACE, LLP removed 1,232,629 shares (-71.7%) from their portfolio in Q4 2025, for an estimated $3,710,213
- BLACKROCK, INC. added 1,113,489 shares (+19.6%) to their portfolio in Q4 2025, for an estimated $3,351,601
- AMERIPRISE FINANCIAL INC removed 959,391 shares (-75.1%) from their portfolio in Q4 2025, for an estimated $2,887,766
- LOGOS GLOBAL MANAGEMENT LP removed 900,000 shares (-60.0%) from their portfolio in Q4 2025, for an estimated $2,709,000
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 880,609 shares (+2430.1%) to their portfolio in Q4 2025, for an estimated $2,650,633
- WOODLINE PARTNERS LP added 742,009 shares (+inf%) to their portfolio in Q4 2025, for an estimated $2,233,447
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ACRS Stock Analyst Ratings
Wall Street analysts have issued reports on $ACRS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 01/28/2026
To track analyst ratings and price targets for $ACRS Stock, check out Quiver Quantitative's $ACRS forecast page.
$ACRS Stock Price Targets
Multiple analysts have issued price targets for $ACRS recently. We have seen 3 analysts offer price targets for $ACRS in the last 6 months, with a median target of $10.0.
Here are some recent targets:
- Jeff Jones from Oppenheimer set a target price of $10.0 on 04/16/2026
- Martin Fan from Wedbush set a target price of $8.0 on 03/31/2026
- Raghuram Selvaraju from HC Wainwright & Co. set a target price of $16.0 on 03/19/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
